Most Recent
A judge has found four drivers working with transport company Avert Logistics are independent contractors despite the business supplying vehicles for them.
Forum Finance director Vince Tesoriero has been caught out for failing to declare over $150,000 to the court, as he took the stand to defend evidence given about his financial position in Westpac’s fraud case against him.
T-shirts and face masks sold on Redbubble violate Hells Angels' trademarks, a judge has found, banning the online marketplace from further sales of infringing products and awarding damages to the motorcycle group.
The law firm whose probe into allegedly defective diesel particulate filters in Toyota cars has led to a verdict worth as much as $2 billion against the car maker has launched a class action investigation into diesel particulate filter issues with two models of Isuzu utes.
A judge has put a climate change class action on behalf of Torres Strait Islanders on a tight timetable and committed herself to handing down judgment soon after trial, saying the case was one of "considerable urgency".
The finance arm of luxury car maker BMW has been given the greenlight to repossess a red 2019 Ferrari 488 Pista Coupe purchased by alleged fraudster Bill Papas' defunct Forum Group.
The lead applicants in a climate change class action by Torres Strait Islanders are hoping the Commonwealth will admit climate change targets set by the Morrison government were “woefully inadequate”, a court heard Friday.
Booktopia has resolved a case by the consumer regulator alleging the online book retailer's policy that required customers to request a refund within two business days of purchase was misleading.
Investment manager Payton Securities has lost a bid to recoup claimed losses over $1.4 million stemming from an allegedly negligent property valuation by Bertacco Ferrier, with a judge finding that the company had not retained the valuer and was not a party to the valuation.
German pharmaceutical giant Bayer, which is facing a legal bid by generic drug maker Sandoz to invalidate patents covering blood clot drug Xarelto, is seeking to amend one of the patents in dispute.